Latest News on USNA

Financial News Based On Company


Advertisement
Advertisement

Aquestive Therapeutics ( AQST ) Soars 14.8%: Is Further Upside Left in the Stock?

https://www.zacks.com/stock/news/2754545/aquestive-therapeutics-aqst-soars-148-is-further-upside-left-in-the-stock
Aquestive Therapeutics (AQST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

USNA vs. STVN: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2751634/usna-vs-stvn-which-stock-is-the-better-value-option
Investors with an interest in Medical - Drugs stocks have likely encountered both USANA Health Sciences ( USNA Quick QuoteUSNA - ) and Stevanato Group ( STVN Quick QuoteSTVN - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.

Is USANA Health Sciences ( USNA ) a Great Value Stock Right Now?

https://www.zacks.com/stock/news/2751410/is-usana-health-sciences-usna-a-great-value-stock-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

5 Undervalued Stocks That Are Worth Buying in September

https://www.zacks.com/stock/news/2748627/5-undervalued-stocks-that-are-worth-buying-in-september
StoneCo, USANA Health Sciences, KT, PagSeguro Digital and Itron stand out as undervalued picks with solid growth prospects this September.

Should Value Investors Buy Grifols ( GRFS ) Stock?

https://www.zacks.com/stock/news/2748245/should-value-investors-buy-grifols-grfs-stock
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Advertisement

USNA or STVN: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2744368/usna-or-stvn-which-is-the-better-value-stock-right-now
USNA vs. STVN: Which Stock Is the Better Value Option?

4 Value Stocks Every Investor Should Hold in Volatile Times

https://www.zacks.com/stock/news/2740915/4-value-stocks-every-investor-should-hold-in-volatile-times
StoneCo, CVS, Integer Holdings and USANA emerge as attractive value stocks with low cash-flow ratios and solid growth outlooks.

Should Value Investors Buy USANA Health Sciences ( USNA ) Stock?

https://www.zacks.com/stock/news/2740767/should-value-investors-buy-usana-health-sciences-usna-stock
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Value Investing: 5 Undervalued Stocks Worth Adding to Your Portfolio

https://www.zacks.com/stock/news/2740685/value-investing-5-undervalued-stocks-worth-adding-to-your-portfolio
StoneCo, CVS Health, KT, KB Financial and USANA Health stand out as undervalued picks with low P/B ratios and solid growth prospects.

USNA vs. STVN: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2702768/usna-vs-stvn-which-stock-is-the-better-value-option
Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences ( USNA Quick QuoteUSNA - ) or Stevanato Group ( STVN Quick QuoteSTVN - ) . But which of these two stocks presents investors with the better value opportunity right now?
Advertisement

5 Low Price-to-Book Stocks to Add to Your Portfolio in August

https://www.zacks.com/stock/news/2667912/5-low-price-to-book-stocks-to-add-to-your-portfolio-in-august
STNE, CVS, KT, KB and USNA stand out in August for low P/B ratios and strong growth forecasts, making them value stock contenders.

Are Investors Undervaluing USANA Health Sciences ( USNA ) Right Now?

https://www.zacks.com/stock/news/2667636/are-investors-undervaluing-usana-health-sciences-usna-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Rigel Pharmaceuticals ( RIGL ) Right Now?

https://www.zacks.com/stock/news/2638529/are-investors-undervaluing-rigel-pharmaceuticals-rigl-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

USANA Health ( USNA ) Upgraded to Buy: Here's Why

https://www.zacks.com/stock/news/2613232/usana-health-usna-upgraded-to-buy-heres-why
USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

USNA or ZTS: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2613116/usna-or-zts-which-is-the-better-value-stock-right-now
USNA vs. ZTS: Which Stock Is the Better Value Option?
Advertisement

Should Value Investors Buy Merck KGaA ( MKKGY ) Stock?

https://www.zacks.com/stock/news/2612304/should-value-investors-buy-merck-kgaa-mkkgy-stock
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

USANA Health Sciences ( USNA ) Q2 Earnings and Revenues Top Estimates

https://www.zacks.com/stock/news/2604735/usana-health-sciences-usna-q2-earnings-and-revenues-top-estimates
USANA Health (USNA) delivered earnings and revenue surprises of +37.04% and +4.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

USNA vs. STVN: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2511147/usna-vs-stvn-which-stock-is-the-better-value-option
Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences ( USNA Quick QuoteUSNA - ) or Stevanato Group ( STVN Quick QuoteSTVN - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find ...

USANA Health ( USNA ) Upgraded to Buy: Here's What You Should Know

https://www.zacks.com/stock/news/2507005/usana-health-usna-upgraded-to-buy-heres-what-you-should-know
USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is USANA Health Sciences ( USNA ) Stock Undervalued Right Now?

https://www.zacks.com/stock/news/2506443/is-usana-health-sciences-usna-stock-undervalued-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Advertisement

5 Low Price-to-Book Value Stocks That You Can Buy in June

https://www.zacks.com/stock/news/2506246/5-low-price-to-book-value-stocks-that-you-can-buy-in-june
The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.

USANA Health Sciences ( USNA ) Q1 Earnings and Revenues Surpass Estimates

https://www.zacks.com/stock/news/2453133/usana-health-sciences-usna-q1-earnings-and-revenues-surpass-estimates
USANA Health (USNA) delivered earnings and revenue surprises of 4.29% and 2.67%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Ionis Pharmaceuticals ( IONS ) Surges 8.9%: Is This an Indication of Further Gains?

https://www.zacks.com/stock/news/2443286/ionis-pharmaceuticals-ions-surges-89-is-this-an-indication-of-further-gains
Ionis Pharmaceuticals (IONS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

USANA Exec. Chairman Kevin Guest Celebrates Guitar Month, Stress Awareness Month for Harmony - Usana Health Sciences ( NYSE:USNA )

https://www.benzinga.com/pressreleases/25/04/n44582669/usana-exec-chairman-kevin-guest-celebrates-guitar-month-stress-awareness-month-for-harmony
SALT LAKE CITY, April 1, 2025 /PRNewswire/ -- USANA Health Sciences USNA Executive Chairman Kevin Guest marks April's convergence of International Guitar Month and Stress Awareness Month, as a perfect pairing that celebrates the healing power of music for mental well-being.

USANA Health Sciences ( USNA ) Surpasses Q4 Earnings and Revenue Estimates

https://www.zacks.com/stock/news/2421544/usana-health-sciences-usna-surpasses-q4-earnings-and-revenue-estimates
USANA Health (USNA) delivered earnings and revenue surprises of 30.61% and 2.43%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Advertisement

Should Value Investors Buy USANA Health Sciences ( USNA ) Stock?

https://www.zacks.com/stock/news/2418639/should-value-investors-buy-usana-health-sciences-usna-stock
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director

https://www.globenewswire.com/news-release/2025/02/20/3029404/0/en/NewGen-Receives-Continued-Nasdaq-Listing-Approval-and-Announces-New-Business-Development-Director.html
Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development Initiatives ...

NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director - NewGenIvf Group ( NASDAQ:NIVF )

https://www.benzinga.com/pressreleases/25/02/g43842294/newgen-receives-continued-nasdaq-listing-approval-and-announces-new-business-development-director
Company Granted Request to Continue its Listing on Nasdaq Appoints Thorain Ko to Lead Business Development Initiatives

5 Low Price-to-Book Stocks Worthy of Value Investors' Attention

https://www.zacks.com/stock/news/2417766/5-low-price-to-book-stocks-worthy-of-value-investors-attention
The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, KT, GBX, USNA and ENS are some such stocks.

USNA or STVN: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2416375/usna-or-stvn-which-is-the-better-value-stock-right-now
USNA vs. STVN: Which Stock Is the Better Value Option?
Advertisement

Are Investors Undervaluing Takeda Pharmaceutical Co. ( TAK ) Right Now?

https://www.zacks.com/stock/news/2416221/are-investors-undervaluing-takeda-pharmaceutical-co-tak-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Neurocrine Biosciences ( NBIX ) Q4 Earnings and Revenues Lag Estimates

https://www.zacks.com/stock/news/2411530/neurocrine-biosciences-nbix-q4-earnings-and-revenues-lag-estimates
Neurocrine (NBIX) delivered earnings and revenue surprises of -35.90% and 0.16%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

5 Promising Price-to-Book Value Stocks to Buy in February

https://www.zacks.com/stock/news/2410774/5-promising-price-to-book-value-stocks-to-buy-in-february
The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, USNA, GBX, KT and ENS are some such stocks.

USNA vs. STVN: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2405952/usna-vs-stvn-which-stock-is-the-better-value-option
Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences ( USNA Quick QuoteUSNA - ) or Stevanato Group ( STVN Quick QuoteSTVN - ) . But which of these two stocks offers value investors a better bang for their buck right now?

Are Investors Undervaluing USANA Health Sciences ( USNA ) Right Now?

https://www.zacks.com/stock/news/2405596/are-investors-undervaluing-usana-health-sciences-usna-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Advertisement

Is USANA Health Sciences ( USNA ) Stock Undervalued Right Now?

https://www.zacks.com/stock/news/2395751/is-usana-health-sciences-usna-stock-undervalued-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Value Investor Highlights: Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care

https://www.zacks.com/stock/news/2395466/zacks-value-investor-highlights-alaska-air-heidrick-struggles-usana-health-sciences-general-motors-and-fresenius-medical-care
Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care have been highlighted in this Value Investor article.

5 Classic Value Stocks for 2025

https://www.zacks.com/stock/news/2395291/5-classic-value-stocks-for-2025
These stocks are cheap and have top Zacks Ranks of Strong Buy or Buy.

January Effect Builds Up Momentum: 5 Small-Cap Stocks to Buy

https://www.zacks.com/stock/news/2394256/january-effect-builds-up-momentum-5-small-cap-stocks-to-buy
After logging its worst month, the Russell 2000 Index is up 0.4% in the initial week of 2025, indicating that the "January Effect" is building up momentum.

5 Promising Price-to-Book Value Stocks to Buy in 2025

https://www.zacks.com/stock/news/2390572/5-promising-price-to-book-value-stocks-to-buy-in-2025
The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, USNA, CIO, TRTX and ITRI are some such stocks.
Advertisement

New Strong Buy Stocks for December 30th

https://www.zacks.com/commentary/2386415/new-strong-buy-stocks-for-december-30th
CCRD, APPN, USNA, TRDA and NRXP have been added to the Zacks Rank #1 (Strong Buy) List on December 30, 2024.

USNA or UCBJY: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2388928/usna-or-ucbjy-which-is-the-better-value-stock-right-now
USNA vs. UCBJY: Which Stock Is the Better Value Option?

Is USANA Health Sciences ( USNA ) a Great Value Stock Right Now?

https://www.zacks.com/stock/news/2388799/is-usana-health-sciences-usna-a-great-value-stock-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

USANA Health Sciences ( USNA ) Q3 Earnings Surpass Estimates

https://www.zacks.com/stock/news/2355283/usana-health-sciences-usna-q3-earnings-surpass-estimates
USANA Health (USNA) delivered earnings and revenue surprises of 14.29% and 3.95%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

PTC Therapeutics ( PTCT ) Surges 16.5%: Is This an Indication of Further Gains?

https://www.zacks.com/stock/news/2348539/ptc-therapeutics-ptct-surges-165-is-this-an-indication-of-further-gains
PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Advertisement

USANA Executive Chairman Kevin Guest Celebrates Country Music Month, Mental Balance - Usana Health Sciences ( NYSE:USNA )

https://www.benzinga.com/pressreleases/24/10/n41114773/usana-executive-chairman-kevin-guest-celebrates-country-music-month-mental-balance
SALT LAKE CITY, Oct. 1, 2024 /PRNewswire/ -- As vibrant melodies of Country Music Month fill the air this October, there is no better time to explore the symphony between our love for music and the pursuit of mental wellness.

Profound Medical ( PROF ) Moves 5.1% Higher: Will This Strength Last?

https://www.zacks.com/stock/news/2342338/profound-medical-prof-moves-51-higher-will-this-strength-last
Profound Medical (PROF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Xencor Surges 10.5%: Is This an Indication of Further Gains? - Usana Health Sciences ( NYSE:USNA ) , Xencor ( NASDAQ:XNCR )

https://www.benzinga.com/general/biotech/24/09/40828385/xencor-surges-10-5-is-this-an-indication-of-further-gains
Xencor XNCR shares rallied 10.5% in the last trading session to close at $21.13. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 19.8% gain over the past four weeks.

Xencor ( XNCR ) Surges 10.5%: Is This an Indication of Further Gains?

https://www.zacks.com/stock/news/2334996/xencor-xncr-surges-105-is-this-an-indication-of-further-gains
Xencor (XNCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

eXp Realty Welcomes Donald Cherry as Vice President of Sustainability - eXp World Holdings ( NASDAQ:EXPI )

https://www.benzinga.com/pressreleases/24/07/g39983645/exp-realty-welcomes-donald-cherry-as-vice-president-of-sustainability
BELLINGHAM, Wash., July 26, 2024 ( GLOBE NEWSWIRE ) -- eXp Realty®, "the most agent-centric real estate brokerage on the planet™" and the core subsidiary of eXp World Holdings, Inc.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement